Hetero- and adaptive resistance to polymyxin B in OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates

Annals of Clinical Microbiology and Antimicrobials

Volumn 12, Issue 1, 2013, Pages

  Barin, Juliana ^a   Martins, Andreza Francisco ^b   Heineck, Bianca Lucia ^a   Barth, Afonso Luis ^c   Zavascki, Alexandre Prehn ^c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b IPA   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Acinetobacter baumannii; Adaptive resistance; Carbapenemase; Colistin; Hetero resistance; Multidrug resistance; Polymyxin B; Polymyxins

Indexed keywords

CARBAPENEM; COLISTIN; POLYMYXIN B; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIUM ISOLATE; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; HOSPITAL PATIENT; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; ACINETOBACTER INFECTION; ADAPTATION; BRAZIL; DRUG EFFECTS; DRUG TOLERANCE; ENZYMOLOGY; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; SECRETION (PROCESS);

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADAPTATION, BIOLOGICAL; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; BRAZIL; DRUG RESISTANCE, BACTERIAL; DRUG TOLERANCE; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMYXIN B;

EID: 84879817991     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-12-15     Document Type: Article

References (19)

1. Vila J, Pachón J. Therapeutic options for Acinetobacter baumannii infections: an update. Expert Opin Pharmacother 2012, 13:2319-2336. 10.1517/14656566.2012.729820, 23035697.
2. Zavascki AP, Goldani LZ, Li J, Nation RL. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother 2007, 60:1206-1215. 10.1093/jac/dkm357, 17878146.
3. Gales AC, Jones RN, Sader HS. Contemporary activity of colistin and polymyxin B against a worldwide collection of gram-negative pathogens: results from the SENTRY antimicrobial surveillance program (2006-09). J Antimicrob Chemother 2011, 66:2070-2074. 10.1093/jac/dkr239, 21715434.
4. Falagas ME, Rafailidis PI, Matthaiou DK. Resistance to polymyxins: mechanisms, frequency and treatment options. Drug Resist Updat 2010, 13:132-138. 10.1016/j.drup.2010.05.002, 20843473.
5. Cai Y, Chai D, Wang R, Liang B, Bai N. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother 2012, 67:1607-1615. 10.1093/jac/dks084, 22441575.
6. Falagas ME, Makris GC, Dimopoulos G, Matthaiou DK. Heteroresistance: a concern of increasing clinical significance?. Clin Microbiol Infect 2008, 14:101-104.
7. Skiada A, Markogiannakis A, Plachouras D, Daikos GL. Adaptive resistance to cationic compounds in Pseudomonas aeruginosa. Int J Antimicrob Agents 2011, 37:187-193. 10.1016/j.ijantimicag.2010.11.019, 21295448.
8. Pournaras S, Ikonomidis A, Markogiannakis A, Spanakis N, Maniatis AN, Tsakris A. Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems. J Med Microbiol 2007, 56:66-70. 10.1099/jmm.0.46816-0, 17172519.
9. Yau W, Owen RJ, Poudyal A, Bell JM, Turnidge JD, Yu HH, Nation RL, Li J. Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme. J Infect 2009, 58:138-144. 10.1016/j.jinf.2008.11.002, 19058855.
10. Meletis G, Tzampaz E, Sianou E, Tzavaras I, Sofianou D. Colistin heteroresistance in carbapenemase-producing Klebsiella pneumonia. J Antimicrob Chemother 2011, 66:946-947. 10.1093/jac/dkr007, 21393203.
11. Higgins PG, Lehmann M, seifert H. Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2010, 35:305-314.
12. Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 2006, 44:2974-2976. 10.1128/JCM.01021-06, 1594603, 16891520.
13. Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing: Twenty-First Informational Supplement 2011, Wayne, PA, USA: CLSI document M100-S21, Clinical and Laboratory Standards Institute (CLSI).
14. Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, Heersma H, Dijkshoorn L. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 2005, 43:4328-4335. 10.1128/JCM.43.9.4328-4335.2005, 1234071, 16145073.
15. Fernández L, Gooderham WJ, Bains M, McPhee JB, Wiegand I, Hancock RE. Adaptive resistance to the " Last Hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS. Antimicrob Agents Chemother 2010, 54:3372-3382. 10.1128/AAC.00242-10, 2916309, 20547815.
16. Li J, Rayner CR, Nation RL, Owen RJ, Spelman D, Tan KE, Liolios L. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2006, 50:2946-2950. 10.1128/AAC.00103-06, 1563544, 16940086.
17. Hawley JS, Murray CK, Jorgensen JH. Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy. Antimicrob Agents Chemother 2008, 52:351-352. 10.1128/AAC.00766-07, 2223915, 17954699.
18. Adams MD, Nickel GC, Bajaksouzian S, Lavender H, Murthy AR, Jacobs MR, Bonomo RA. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother 2009, 53:3628-3634. 10.1128/AAC.00284-09, 2737849, 19528270.
19. Moffatt JH, Harper M, Harrison P, Hale JD, Vinogradov E, Seemann T, Henry R, Crane B, St Michael F, Cox AD, Adler B, Nation RL, Li J, Boyce JD. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother 2010, 54:4971-4977. 10.1128/AAC.00834-10, 2981238, 20855724.